Kanabo Group (LSE:KNB) Inventories, Finished Goods : £0.00 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group Inventories, Finished Goods?

Kanabo Group's quarterly finished goods increased from Jun. 2023 (£0.00 Mil) to Dec. 2023 (£0.04 Mil) but then declined from Dec. 2023 (£0.04 Mil) to Jun. 2024 (£0.00 Mil).

Kanabo Group's annual finished goods increased from Dec. 2021 (£0.05 Mil) to Dec. 2022 (£0.06 Mil) but then declined from Dec. 2022 (£0.06 Mil) to Dec. 2023 (£0.04 Mil).

Kanabo Group Inventories, Finished Goods Historical Data

The historical data trend for Kanabo Group's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group Inventories, Finished Goods Chart

Kanabo Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.02

0.05

0.06

0.04

Kanabo Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Inventories, Finished Goods	Get a 7-Day Free Trial									-	0.06	-	0.04	-

Kanabo Group Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Kanabo Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

3WD:Germany

Address

137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ

Website

https://www.kanabogroup.com

Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.

Kanabo Group Headlines

No Headlines